➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Medtronic
Boehringer Ingelheim
McKinsey
Moodys

Last Updated: August 3, 2021

DrugPatentWatch Database Preview

FELBAMATE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Drug Prices for FELBAMATE

See drug prices for FELBAMATE

Recent Clinical Trials for FELBAMATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Laboratorios Grossman, S.A.Phase 3
Instituto Nacional de Salud Publica, MexicoPhase 3
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4

See all FELBAMATE clinical trials

Pharmacology for FELBAMATE

US Patents and Regulatory Information for FELBAMATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms FELBAMATE felbamate TABLET;ORAL 202284-001 Nov 4, 2015 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Mylan Speciality Lp FELBATOL felbamate TABLET;ORAL 020189-002 Jul 29, 1993 AB RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Taro FELBAMATE felbamate TABLET;ORAL 207093-002 Apr 20, 2017 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Taro FELBAMATE felbamate SUSPENSION;ORAL 206314-001 Jun 16, 2017 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for FELBAMATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speciality Lp FELBATOL felbamate TABLET;ORAL 020189-002 Jul 29, 1993 ⤷  Try it Free ⤷  Try it Free
Mylan Speciality Lp FELBATOL felbamate SUSPENSION;ORAL 020189-003 Jul 29, 1993 ⤷  Try it Free ⤷  Try it Free
Mylan Speciality Lp FELBATOL felbamate TABLET;ORAL 020189-001 Jul 29, 1993 ⤷  Try it Free ⤷  Try it Free
Mylan Speciality Lp FELBATOL felbamate TABLET;ORAL 020189-001 Jul 29, 1993 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Medtronic
Boehringer Ingelheim
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.